Skip to content
DataLookout
Menu

NCT07449520

Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened
    • Eligibility criteria expanded, about 18 words
    • Study sites: 10 to 12
    • Start date changed from estimate of Mar 2026 to Mar 17, 2026
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Total Body Weight Loss
Timeframe: At the inclusion and 24 months after procedure

Secondary (6)

Excess weight loss
Body Mass Index (BMI)
Adverse events
Comorbidities improvement
Quality of life improvement
Show 1 moreShow less
Additional treatments

Arms and interventions

All adult patients with obesity scheduled for endoscopic gastroplasty (ESG)

Procedures: Endoscopic sleeve gastroplasty

Sites

12 sites in 2 countries

France 11, Guadeloupe 1